and December 1 2017 had us at $3.18 on the Nasdaq. So clearly the US market has lost confidence in this company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025